Access and Identity Management Analyst II
Owens & MinorSalary not specified
- Full Time
- Junior (1 to 2 years)
$60,000 – $90,000Compensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Information Security, CybersecurityIndustries
Requirements
Candidates should possess a Bachelor’s degree in Computer Science, Information Security, or a related field, and have at least 5 years of experience in Identity and Access Management (IAM) within a complex enterprise environment. Strong knowledge of IAM principles, protocols, and technologies is required, including experience with IGA tools and Directory Services environments such as Azure and AWS. Experience with security frameworks and NIST cybersecurity standards is also beneficial.
Responsibilities
The Identify Access Manager will support enterprise-wide cybersecurity IAM operations using vendor security tools, implement IAM strategy aligned with company objectives, lead the deployment and integration of IGA tool, manage the day-to-day operations of the IAM program, collaborate with cross-functional teams to define IAM policies, coordinate regular audits, provide leadership and guidance to staff, drive adoption of IAM technologies, ensure compliance with regulatory requirements, develop and deliver training programs, design and maintain Directory Services environments, and architect secure IAM designs.
Skills
IAM
IGA Tools
Azure
AWS
Directory Services
Security Frameworks
NIST Cybersecurity Standards
Directory Services
IAM Policies
Compliance
Training
Security Architecture
Legend Biotech
Develops and commercializes cell therapies
About Legend Biotech
Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's cells to combat cancer. Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments.
Franklin Township, New JerseyHeadquarters
2014Year Founded
$146.4MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees